GVR Report cover Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Trends Report

Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Animal Type (Livestock Animals, Companion Animals), By Product, By End Use, By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-4-68038-330-0
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview

The global veterinary antimicrobial susceptibility testing market size was valued at USD 35.73 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2021 to 2028. The growing government initiatives and stringent regulatory guidelines are expected to propel the market growth over the forecast period. For instance, in 2022, new EU legislation will prohibit the use of all types of routine antibiotic usage of antibiotics in farming. The COVID-19 pandemic has had a very low impact on the market. However, the demand for antimicrobial susceptibility testing kits has been drastically lowered due to the reduced vet visits during the lockdown. The demand for animal protein and livestock products has also reduced during the first two quarters of 2020. The market showed a V-shaped recovery and vet visits became redeemed, which is bolstering the growth. According to IDEXX, the U.S. clinic visit increased by 6% in Q4 2020, which is expected to fuel the revenue growth over the forecast period.

U.S. veterinary antimicrobial susceptibility testing market size, by product, 2018 - 2028 (USD Billion)

According to OECD, the amount of antimicrobials used in food animals will increase from 63,151 tons to 105, 596 tons by 2030 globally. Approximately, 45mg of antimicrobials are used to produce 1 kg of beef. Moreover, 148mg of antimicrobials are used for 1 kg of chicken. The top 5 consumers of antimicrobials are China, the U.S., Brazil, India, and Germany, respectively. For instance, in the U.S., around 80% of the annual consumption of antimicrobials was for food animals in 2019.

The livestock population globally has been rapidly increasing. The demand for livestock products is growing in developing and developed countries. This has led to a rise in concerns over the health of livestock. According to the United States Department of Agriculture, National Agricultural Statistics Service, as of January 2021, the number of cattle and calves in the U.S. was 93,594,500 and that of the beef cow was 31,157,600. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. There is also an increasing demand for healthy, sustainable, and high-quality meat products, especially those with comparatively few or no antibiotics. This is, in turn, increasing the demand for antimicrobial susceptibility testing (AST).

Animal Type Insights

Livestock animals, also known as production animals, held the largest share of over 64.0% in 2020. This can be attributed to the growing consumption of animal proteins and stringent regulations regarding the usage of antibiotics in food animals. China’s antibiotic consumption by the agriculture sector has decreased by around 58% from 2014 to 2019, according to the ministry bulletin. The Netherlands has decreased its antibiotics usage by around 56% within 5 years. The most common antibiotics used by farmers are for growth promotion.

The companion animals segment is expected to witness significant growth over the forecast period. An increase in the number of pet owners is driving the need for vaccinations for companion animals. According to the Pet Food Manufacturers Association, it is estimated that in 2020, 41% of households were estimated to own a pet in the U.K., accounting for 12 million pets. According to the Canadian Veterinary Medical Association, as of 2020, there were 8.1 million and 7.7 million households with cats and dogs, respectively. The most common antimicrobials used in companion animals are amoxicillin-clavulanate. The transmission of resistance through cats and dogs to humans is increasing at an alarming rate, which is further increasing the demand for antimicrobial susceptibility testing.

Product Insights

Automated AST instruments held the largest revenue share of over 41.0% in 2020. The growth can be attributed to the increasing adoption of these instruments and their higher cost as compared to other methods. Moreover, these instruments have improved the turnaround time and time of identification, which is propelling the growth. The instruments have advanced computer software to interpret susceptibility patterns for each organism and give error-free results.

Disks are most commonly used for AST in veterinary laboratories. The method uses small discs infused with specific concentrations of antibiotics to determine sensitivity. The method is time-consuming and the process is qualitative. This method is popular due to its cost and ease of operation. The other methods include the antimicrobial gradient method, intrinsic resistance, and acquired resistance.

End-use Insights

Veterinary reference labs held the largest revenue share of over 55.0% in 2020 owing to the most number of testing of samples done under these facilities. These laboratories use diagnostic kits available in the market to serve pet owners, farm owners, government-related programs, or research collaborations. The antimicrobial susceptibility tests (ASTs) can provide essential information to select the most appropriate antimicrobials for a specific treatment. This will lead to the overall reduction of antimicrobial agents in animals.

Global veterinary antimicrobial susceptibility testing market share, by end use, 2020 (%)

The veterinary research institutes segment is expected to witness lucrative growth over the forecast period. The rising adoption of pet animals and increasing healthcare spending on pets are factors fueling the growth of research institutes and universities. The research institutes play a major role in the usage and development of these tests. The main functions taken care of by these research institutes include identification, deployment, and development of novel diagnostic techniques or procedures for research and monitoring purposes of newly emerging or existing diseases in animals and reduce the over-usage of antibiotics.

Regional Insights

Asia Pacific held the largest share of over 33.0% in 2020 owing to the presence of a large livestock population in this region. Increasing demand for milk and animal-based protein and government initiatives are propelling the market growth in this region. Moreover, increasing adoption of pet animals, growing health concerns about pets, and increasing usage of antibiotics in animals are the factors driving the market in Asia Pacific countries, such as India and China. Furthermore, the market growth in the region can be attributed to the significantly high cattle population. For instance, China and India constitute more than 30% of the global population of cattle.

North America held the second-largest share in 2020 owing to the presence of major industry players. According to the FDA, as of 2017, the use of antibiotics for growth promotion in farm animals was banned in the U.S. USDA’s Food Safety and Inspection Service (FSIS) conducts a monitoring program for successful elimination of antibiotics from animals before slaughtering. Moreover, the market is anticipated to grow due to increasing animal healthcare centers and practitioners. For instance, according to the AVMA report, the country accounted for 116,091 veterinary practitioners in the year 2019; however, in 2020, the number increased to 118,624 practitioners in the country.

Key Companies & Market Share Insights

The market is fragmented with many large and small players. These players implement various strategic initiatives to achieve their objectives and increase market share. New product launches, regional expansion, partnerships, and mergers & acquisitions are some of the initiatives deployed by key companies. For instance, in February 2020, Becton, Dickinson and Company partnered with the Fleming Fund in order to help low and middle-income countries to handle antimicrobial resistance. In September 2019, Synbiosis launched AutoCol, an automated colony counter system, which would help to count colonies up to 100 plates within just 30 minutes. Some prominent players in the global veterinary antimicrobial susceptibility testing market include:

  • BioMérieux SA 

  • Becton, Dickinson and Company

  • Synbiosis

  • Thermo Fisher Scientific

  • Bruker Corporation

  • Danaher Corporation

  • Condalab

  • Bioguard Corporation

  • Liofilchem S.r.l.

  • HiMedia Laboratories

  • Bio-Rad Laboratories

  • Neogen Corporation

Veterinary Antimicrobial Susceptibility Testing Market Report Scope

Report Attribute


Market size value in 2021

USD 37.16 billion

Revenue forecast in 2028

USD 52.78 billion

Growth Rate

CAGR of 5.1% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion & CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Animal type, product, end-use, region

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Brazil; Mexico; South Africa

Key companies profiled

BioMérieux SA; Becton, Dickinson and Company; Synbiosis; Thermo Fisher Scientific; Bruker Corporation; Danaher Corporation; Condalab; Bioguard Corporation; LiofilchemS.r.l.; HiMedia Laboratories; Bio-Rad Laboratories; Neogen Corporation

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this report, Grand View Research has segmented the global veterinary antimicrobial susceptibility testing market report on the basis of animal type, product, end-use, and region:

  • Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Livestock Animals

      • Cattle

      • Poultry

      • Pigs

      • Others

    • Companion Animals

      • Cats

      • Dogs

      • Horses

      • Others

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Disks & Plates

    • Culture Media

    • Accessories & Consumables

    • Automated AST Instruments

  • End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Veterinary Reference Lab

    • Veterinary Research Institutes

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

ESOMAR Certified Member Great Place to Work Certified

ESOMAR & Great Work to Place Certified

ISO 9001:2015 & 27001:2022 Certified

ISO 9001:2015 & 27001:2022 Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.